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Industry and the profession of medicine:
Balancing appropriate relationships with the need
for innovation
Jack Lewin, MD, and Thomas E. Arend Jr, JD, Washington, DC
Much has been made over the last few years about conflicts of interest in the health care community’s relationships with
industry members, including individual physicians, academic medical centers, and professional organizations. Not only
has the Department of Justice (DOJ) been investigating questionable relationships, but House and Senate Oversight
Committees have also weighed in on real and perceived conflicts. Most recently, the Physician Payments Sunshine Act of
2010 requires companies to begin recording any physician payments, including stock options, research grants, knick-
knacks, consulting fees, and travel to medical conferences that are worth more than ten dollars in 2012 and report them
on March 31, 2013. To date, the American College of Cardiology (ACC) has developed and instituted one of the most
stringent policies in the medical community to ensure that support from industry has no influence on any of its clinical
documents. Furthermore, the need for the ACC’s “Principles for Relationships with Industry,” the organization’s guide
in nine key operational areas, are critical given that, when it comes to industry, properly managed partnerships are
absolutely essential to maintaining scientific progress in cardiology and other specialties. The ACC relies on industry
funding to advance cardiovascular research, as well as cardiovascular workforce training, practitioner diversity, medical
education, and life-long learning.Without this funding, the ACC’s ability to providemeaningful, unbiased education and
to improve quality of care would be far more limited than that which is currently offered to its members and, ultimately,
patients. Rather than restricting industry funding for such activities, the focus should instead be on transparency and
actively and appropriately managing industry relationships. Ethical and appropriate partnerships with industry can prove
beneficial in funding of education, research, and quality improvement activities. In addition, they are critical in the
advancement of the quality of care for patients. The challenge is for medical societies to help the media, the public, and
policymakers better understand the role of industry in promoting research, education, and innovation in medicine.
(J Vasc Surg 2011;54:47S-9S.)
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sMuch has been made over the last few years about
conflicts of interest in the health care community’s relation-
ships with industry. This includes relationships with indi-
vidual physicians as well as those with academic medical
centers and professional organizations.
Speaking at the American Academy of Orthopedic Sur-
geons (AAOS) 2010 Annual Meeting, Kirk Ogrosky, JD,
then-deputy chief for health care fraud in the criminal
division of the USDepartment of Justice (DOJ), said, “I’ve
been investigating health care fraud for 15 years, but within
the last year, health care fraud has been raised to Cabinet-
level attention.”1 Not only has the DOJ been investigating
questionable relationships, but House and Senate Over-
sight Committees have also weighed in on real and per-
ceived conflicts.2 Most recently, the Physician Payments
Sunshine Act of 2010 requires companies to begin record-
ing any physician payments that are worth more than ten
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doi:10.1016/j.jvs.2011.04.069ollars in 2012 and report them onMarch 31, 2013.3 That
ncludes stock options, research grants, knickknacks, con-
ulting fees, and travel to medical conferences. The details
ill be posted in a searchable database starting September
0, 2013.
Reading the writing on the wall, the American College
f Cardiology (ACC) has been taking its commitment to
rofessionalism and a transparent relationship with all of its
ndustry sources of funding to heart over the past several
ears.4 To date, the College has developed and instituted
ne of the most stringent policies in the medical com-
unity to ensure that support from industry has no
nfluence on any of its clinical documents, such as prac-
ice guidelines and appropriate use criteria, or the con-
ent of ACC-sponsored medical education.
The ACC’s “Principles for Relationships with Indus-
ry” serve as the organization’s guide in nine key areas of
peration: (1) advertising, (2) charitable donations, (3)
linical document development, (4) continuing medical
ducation, (5) exposition, (6) governance, (7) government
rants and foundation support, (8) registries, and (9) spon-
orships.5 These principles underscore the College’s com-
itment to full transparency and the very highest ethical
tandards.
The need for these principles is critical given that,
hen it comes to industry, properly managed partner-
hips are absolutely essential to maintaining scientific
rogress in cardiology and other specialties. Evidence-
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sures, and appropriate use criteria often lag in point-of-care
clinical application for a decade; and advances in medical
science often outpace the creation or updating of these
measures. In addition, the federal government is unable
and unprepared to assist in the translation of science or
ensuring its application. There is a need for more, and
better, educational venues for physicians and health profes-
sionals to maintain scientific and clinical competencies as
the pace of science accelerates. With strict and carefully
constructed relationships that prevent bias or commercial
interest, why should industry not share some responsibility
for education that requires funding and life-long learning
for medical professionals?
Some in Congress, the medical community, the lay
press, and elsewhere have suggested that there should be
absolutely no use of industry funds for any medical school
or organization activity. However, given the scarcity of
public funding for research and publications and the rela-
tively high cost of education, this position would make it
very difficult for medical societies to carry out their missions
and enhance quality of care.6 In fact, we believe that
industry, in addition to its role in developing new drugs and
devices that advance the treatment of cardiovascular dis-
ease, has an obligation and expectation to provide funding
for the education of practitioners as part of its social con-
tract with patients, clinicians, and society as a whole.
In terms of the ACC, the College relies on industry
funding to advance cardiovascular research, as well as car-
diovascular workforce training, practitioner diversity, med-
ical education, and life-long learning. Association dues
cannot realistically cover education costs, and it is increas-
ingly difficult given the economic pressures of medical
practice to attract physicians and care providers to continue
to learn and remain current outside of the academic envi-
ronment. As it is, cardiologists now pay the lion’s share of
their continuing medical education and maintenance of
certification costs, including attendance at the ACC’s own
meetings. Industry grants, carefully firewalled from bias,
provide additional simulation and other features that attract
busy cardiovascular professionals to learn. Without this
funding, the ACC’s ability to provide meaningful, unbiased
education and to improve quality of care would be far more
limited than that which is currently offered to its members
and, ultimately, patients. Rather than restricting industry
funding for such activities, the focus should instead be on
transparency and actively and appropriately managing in-
dustry relationships.
Disclosure is of the utmost importance. The College
has strict organizational firewalls between the develop-
ment and fundraising related to commercial support and
the College’s programmatic activities and personnel.
These firewalls are designed to ensure that the American
College of Cardiology’s (ACC’s) relationships with drug
and device companies never influence the scientific or educa-
tional content the College produces. In addition, the ACC
adheres to both internal and external policies that prohibit
companies providing support from exercising any influence or aontrol over programmatic content, speaker/faculty selec-
ion, program format, planning, partnering arrangements,
rogram evaluation methods, and related matters.7
Most recently, the College reaffirmed its commitment
o transparency by signing on to the “Code for Interactions
ith Companies” released by the Council of Medical Spe-
ialty Societies.8 The code is meant to increase transparency
nd set a universal standard for independent program de-
elopment and independent leadership. The ACC made
ignificant contributions to the final code, based on its own
elationships with industry principles.
In addition, the College has developed new principles
elated to the development of clinical documents, such as
uidelines, scientific advisories, and appropriate use criteria.
iven that guideline and clinical document development is
key component of the ACC mission, these new principles
re designed to ensure that authors involved in the devel-
pment of clinical documents fully disclose all relationships
ith industry and other entities to eliminate the possi-
ility of undue bias. The breadth of disclosures include
esearch funding, consulting relationships, stock owner-
hip, advisory boards, data safety monitoring boards, and
ncompensated potential “intellectual conflicts.” The
CC has worked collaboratively with the American
eart Association (AHA) and other specialty societies to
nsure relationships with industry policies on document
reation are identical.
Under the new principles, all clinical document au-
hors, including organizational representatives of ACC
oundation (ACCF) document writing committees (eg,
uidelines, performance measures, clinical alerts, scientific
tatements, expert consensus documents), must annually
isclose all relationships with industry and other entities
sing ACC’s Electronic Disclosure Database. In addition,
ll ACCFwriting committees must have a chair without any
elationships that are relevant to the document under de-
elopment. The respective ACCF parent task forces respon-
ible for overseeing clinical practice guidelines, expert con-
ensus documents, appropriate use criteria, etc, must review
nd approve all writing committee appointments and adju-
icate questions or concerns relating to relationships with
ndustry.
The ACC’s Clinical Quality Committee’s Science and
linical Policy Subcommittee has taken on the central role
f addressing broad conflicts of interest issues. When it
omes to writing committees, each committee must have at
east 50% of its members (excluding the chair) without
elevant industry relationships. This means that the respon-
ibility for identifying members without relevant relation-
hips is distributed as evenly and fairly as possible to all
artnering organizations. Partners or collaborating organi-
ations are asked to recommend several alternate represen-
atives to facilitate the implementation of this policy. If
here is difficulty in reaching the 50/50 distribution of
embers with and without relationships, organizations are
sked for alternative names until even distribution is
chieved.
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ation process when it is advisable to have writing group
members with relevant industry relationships to ensure the
scientific rigor related to certain areas of content, the ACC
and the AHA have strict policies in place related to recusing
an individual or individuals with industry relationships from
any text drafting of relevant document sections and/or
from voting on any recommendation relevant to their
relationship(s). Finally, relevant industry relationships for
all writing committees are published with the document
and “comprehensive” documentation is also available elec-
tronically.
The College recognizes that the new principles govern-
ing development of clinical policy documents are, to some
extent, controversial. Some have criticized the policies for
being too constricting, making ideal document creation
quite challenging, while others view these policies as not
strict enough. Ultimately, the ACC is committed to these
new principles and believes these changes will not dilute the
clinical document development process. Rather, transpar-
ency and a rigorous process to manage relationships with
industry is the best policy for everyone involved in the
development of organizational documents and standards.
Ethical and appropriate partnerships with industry can
prove beneficial in funding of education, research, and
quality improvement activities. In addition, they are critical
in the advancement of the quality of care for patients. The
challenge is for medical societies to help the media, the
public, and policymakers better understand the role of
industry in promoting research, education, and innovation
in medicine. We need to help them ensure that competing
clinical views are aired and balanced.We also need to be out
in front advising them when their words or actions related
to relationships with industry issues may be misguided
and/or potentially counterproductive to the creation of the
best possible evidence-based documents. It is the College’s
hope that by developing thorough and transparent stan-
dards, professional societies and health care providers can Sebuild trust in the health care system and avoid pressing
hreats to physician autonomy. The ultimate goal: to make
ure that any relationship is managed in a way that ensures
nbiased, evidence-based, and balanced reviews of science,
egardless of funding sources.
More information on the ACC’s relationships with
ndustry principles, as well as the disclosures of trustees,
tate chapter governors, and committee chairs, is available
n ACC’s CardioSource.org Web site.
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